The pharmaceutical industry is steadily facing the challenge of developing new and effective drugs to combat a growing range of diseases. Traditionally, this process has been time-consuming, costly, and often unsuccessful. However, recent advances in artificial intelligence (AI) are disrupting the landscape of drug discovery, offering unprecedented

Pharmacogenomics holds immense opportunity to revolutionize drug development by assessing the influence of an individual's genetic makeup on their reaction to medications. This area investigates the correlation between genes and drug action, paving the way for more precise therapies. By pinpointing genetic markers that forecast drug outcomes, pharm